Identification of clinically relevant mechanisms of resistance to endocrine therapy plus CDK4/6 inhibitors in ER+/HER2- advanced breast cancerResearch Project | 01.10.2026 - 30.09.2027 Imported from Grants Tool 4730084FundingIdentification of clinically relevant mechanisms of resistance to endocrine therapy plus CDK4/6 inhibitors in ER+/HER2- advanced breast cancerFoundations / Associations (GrantsTool), 10.2026-09.2027 (12) PI : Bentires-Alj, Mohamed.Members (1) Mohamed Bentires-AljPrincipal InvestigatorResearch Groups Bentires-Alj Lab / Tumor Teterogeneity Metastasis & Resistance
Identification of clinically relevant mechanisms of resistance to endocrine therapy plus CDK4/6 inhibitors in ER+/HER2- advanced breast cancerResearch Project | 01.10.2026 - 30.09.2027
FundingIdentification of clinically relevant mechanisms of resistance to endocrine therapy plus CDK4/6 inhibitors in ER+/HER2- advanced breast cancerFoundations / Associations (GrantsTool), 10.2026-09.2027 (12) PI : Bentires-Alj, Mohamed.
Identification of clinically relevant mechanisms of resistance to endocrine therapy plus CDK4/6 inhibitors in ER+/HER2- advanced breast cancerFoundations / Associations (GrantsTool), 10.2026-09.2027 (12) PI : Bentires-Alj, Mohamed.